These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effect of acyclic nucleoside phosphonates on the HIV-1 integrase in vitro. Abu Sheika G; Tramontano E; Loi AG; Franchetti P; Grifantini M; La Colla P Nucleosides Nucleotides; 1999; 18(4-5):849-51. PubMed ID: 10432692 [TBL] [Abstract][Full Text] [Related]
10. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs. McIntee EJ; Remmel RP; Schinazi RF; Abraham TW; Wagner CR J Med Chem; 1997 Oct; 40(21):3323-31. PubMed ID: 9341906 [TBL] [Abstract][Full Text] [Related]
11. Novel bicyclic sugar modified nucleosides: synthesis, conformational analysis and antiviral evaluation. Kifli N; Thet Htar T; De Clercq E; Balzarini J; Simons C Bioorg Med Chem; 2004 Jun; 12(12):3247-57. PubMed ID: 15158793 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2'3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT). Chang SL; Griesgraber G; Wagner CR Nucleosides Nucleotides Nucleic Acids; 2001 Aug; 20(8):1571-82. PubMed ID: 11554546 [TBL] [Abstract][Full Text] [Related]
13. Acyclic nucleoside phosphonates: a key class of antiviral drugs. De Clercq E; Holý A Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436 [TBL] [Abstract][Full Text] [Related]
14. Phosphate derivatives of AZT display enhanced selectivity of action against HIV 1 by comparison to the parent nucleoside. McGuigan C; Nickson C; Petrik J; Karpas A FEBS Lett; 1992 Sep; 310(2):171-4. PubMed ID: 1397268 [TBL] [Abstract][Full Text] [Related]
15. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus. Balzarini J; Baba M; Pauwels R; Herdewijn P; Wood SG; Robins MJ; de Clercq E Mol Pharmacol; 1988 Mar; 33(3):243-9. PubMed ID: 3258404 [TBL] [Abstract][Full Text] [Related]
16. Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships. de Castro S; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):625-8. PubMed ID: 18066868 [TBL] [Abstract][Full Text] [Related]
17. Nucleoside Inhibitors of Zika Virus. Eyer L; Nencka R; Huvarová I; Palus M; Joao Alves M; Gould EA; De Clercq E; Růžek D J Infect Dis; 2016 Sep; 214(5):707-11. PubMed ID: 27234417 [TBL] [Abstract][Full Text] [Related]
19. [Nucleosides and related compounds which act as inhibitors against replication of HIV-1]. Tanaka H; Miyasaka T Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1250-60. PubMed ID: 7568923 [No Abstract] [Full Text] [Related]